ABBASI A ET AL: "Plasma procalcitonin and risk of type 2 diabetes in the general population", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, vol. 54, no. 9, 15 June 2011 (2011-06-15), pages 2463-2465, XP019934333, ISSN: 1432-0428, DOI: 10.1007/S00125-011-2216-3 (B1)

M.A. STOYLEMEZ: "Procalcitonin is a specific marker of diabetic complication process", EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 18, no. suppl 1, 12 June 2010 (2010-06-12), page 352, XP055037335, Gothenburg, Sweden (B1)

US-A1- 2011 263 438 (B1)

SOYLEMEZ ET AL: "894. A Novel Mechanism between Type II Diabetes Mellitus and Procalcitonin Gene Expression", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, USA, vol. 11, 15 August 2005 (2005-08-15), page 346, XP005016233, American Society of Gene & Cell Therapy 555 East Wells Street Suite 1100 Milwaukee, WI 53202 USA ISSN: 1525-0016 (B1)

SOYLEMEZ ET AL: "A Novel Mechanism between Diabetes Mellitus Complications and Procalcitonin Gene Expression", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, USA, vol. 13, 1 January 2006 (2006-01-01), page S86, XP005675332, American Society of Gene & Cell Therapy 555 East Wells Street Suite 1100 Milwaukee, WI 53202 USA ISSN: 1525-0016 (B1)

MESUT MUTLUOLU ET AL: "Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study", DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, vol. 94, no. 1, 16 May 2011 (2011-05-16), pages 53-56, XP028323696, ISSN: 0168-8227, DOI: 10.1016/J.DIABRES.2011.05.023 [retrieved on 2011-05-19] (B1)